Replies to post #83058 on Biotech Values

[DewDiligence]

Ken Frazier named CEO of MRK (as expected):

http://finance.yahoo.com/news/Merck-Board-Elects-Kenneth-C-bw-4223816709.html?x=0&.v=2

Frazier went from General Counsel to SVP of Pharma and recently received the added title of President, a signal to the investment community that he would become CEO when Dick Clark retired.